When are WIPO ST.25 sample statements not applicable?

Question

Accepted Answer

Source: FAQ (MPEP-Based) BlueIron Update: 2024-09-30 10 Rules 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to the MPEP, WIPO ST.25 sample statements are not applicable to certain patent applications. Specifically: “This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).” For applications filed on or after July 1, 2022, applicants should refer to MPEP §§ 2412 – 2419 for guidance on WIPO ST.26 requirements. This change reflects the transition from WIPO ST.25 to WIPO ST.26 standards for sequence listings in patent applications. Related Rules from the Manual of Patent Examining Procedure 10 rules Collapse Nucleotide and Amino Acid Sequence Disclosures Not Required After July 1, 2022 MPEP 2428 Requirement for Sequence Listings in XML Format MPEP 2412 Sequence Listings Must Be In XML Format MPEP 2412 Support for Sequence Listing Required MPEP 2428 Access to Nucleotide and Amino Acid Sequence Material at NARA MPEP 2412 Source for Sequence Listing Required MPEP 2412 Permitted Sequence Listing Format Must Match CRF MPEP 2428 Required Sequence Listing Must Be In XML Format MPEP 2412 Permitted Nucleotide and Amino Acid Sequences Must Be in XML Format MPEP 1823.02 Required Nucleotide and Amino Acid Sequences Must Be in XML Format MPEP 1848 Required Other Related FAQs 5 FAQs Collapse How do I assert that sequence information is identical in different formats? How do I declare that a sequence listing amendment contains no new matter? What should I include in a statement for replacing a sequence listing? What are the WIPO ST.25 sample statements for sequence listings? What regulation governs the requirements for patent applications with nucleotide and/or amino acid sequence disclosures?